Eckert & Ziegler BEBIG manufactures small, radioactive implants, so called seeds, which are mainly used in LDR brachytherapy for the treatment of localized prostate cancer. The seeds take the form of little capsules containing a minuscule quantity of a radioactive isotope, I-125 (Iodine-125). They are implanted into the prostate, where they remain permanently and destroy the cancer cells. Permanent LDR brachytherapy with seeds is highly effective, especially in early stages of prostate cancer and causes relatively low side effects in comparison to alternative treatment options.
Two different types of seeds are available: IsoSeed® I25.S06 and IsoSeed® I25.S17plus. They are offered in different configurations: as loose (IsoSeed®) or stranded (IsoCord®, IsoStrand®) seeds.
In addition to radioactive implants, Eckert & Ziegler BEBIG provides full installation to hospitals, including treatment planning software, ultrasound scanners and a complete range of accessories, as well as professional training.
For more information regarding our complete implant portfolio, please see www.bebig.com.